Navigation Links
openQ Announces the Formation of a Compliance Advisory Board
Date:6/17/2010

Compliance Advisory Board Provides Expert Guidance Based on Experience at Pfizer, Merck, Medtronic, GTx, Johnson & Johnson, and the University of Virginia School of Medicine.

Charlottesville, VA, San Francisco, CA, New York, NY and Paris, France (PRWEB) June 17, 2010 -- To support its focus on regulatory compliance in the life sciences, openQ has formed a Compliance Advisory Board. Board members include experienced veterans from some of the industry’s leading companies. Their expert guidance will help openQ continue to provide innovative and industry-leading software and data products to the marketplace.

“Compliance is dynamic and we’re looking to our advisors to help keep us ahead of our customers’ evolving needs,” said Jim Zuffoletti , President and Co-Founder of openQ. “The Board’s wealth of industry experience and commitment to compliance will provide an invaluable perspective to openQ and our customers.”

Regulatory compliance has always been an important part of the life sciences. Now, however, regulations are becoming more complex, enforcement has increased, and penalties are more severe. Compliance has become critical for anyone doing business in this industry.

openQ’s Compliance Advisory Board is extremely well positioned to provide guidance that will help openQ provide products and services that mitigate compliance risks while providing efficient and effective tools to their users. By easing the compliance burden, such as manually maintaining records of interactions with doctors, users of openQ solutions can spend their time focused on their core medical mission.

The members of the Compliance Advisory Board are:

Dr. Jann Balmer, RN PhD - Dr. Balmer was appointed as the first full-time Director for Continuing Medical Education of the University of Virginia School of Medicine in December 1990. In her role as Director for CME, the Office of Continuing Medical Education has demonstrated significant growth in meeting the educational needs of physicians and other healthcare professionals. In addition, Dr, Balmer serves as the President of the Alliance for CME. She served as the editor for the Best Practices in CME Handbook distributed by the Alliance for CME for 7 years. She also serves as a speaker at the Annual Meeting of the Alliance for CME, the CME Industry Task Force Meeting, the CME Congress, and other selected organizations.

Gabriel Lazarus - Mr. Lazarus is currently a Marketing Director at Medtronic, in the company's Latin America division, focusing on CardioVascular therapies. At Medtronic he has held a variety of postings, including successful stints in the company's European headquarters in Switzerland, a global marketing role, and a business development position. Prior to entering the medical device industry, Mr. Lazarus was a journalist at Bloomberg News.

Dr. Merrell Magelli - Dr. Merrell Magelli resides in Omaha, Nebraska and is currently Senior Director, Medical Affairs, Senior Medical Director, Drug Safety Officer at GTx, Inc. in Memphis, Tennessee. She has over 12 years of Pharmaceutical Industry Experience as a Medical Science Liaison, Team Leader, Medical Director, Senior Medical Director, and Drug Safety Officer. Prior to Industry, Dr. Magelli was the Clinical Coordinator at Children's Hospital, Omaha, NE where she was in charge of the Investigational Drug Study Program, P&T Committee Co-Chair, IRB Officer, and Board Certified Pain Specialist.

Wendy L. Yarno - Wendy L. Yarno has over 26 years experience in the pharmaceutical industry with Johnson & Johnson and Merck & Co., Inc. She most recently was the Chief Marketing Officer at Merck & Co., Inc. and retired from Merck in 2008. She is currently on the Board of Directors of St. Jude Medical, a medical device company headquartered in Minneapolis, MN, and ADial Pharmaceuticals in Charlottesville, VA. Ms. Yarno is also on the Board of Advisors of HemoShear, LLC., openQ, Inc., and the University of Virginia Patent Foundation.

For more information on openQ, the Compliance Advisory Board, or its members please visit www.openq.com.

About openQ:

Based in Charlottesville, Virginia, OpenQ helps Life Sciences companies manage compliant business processes in their Marketing and Medical Affairs organizations. OpenQ offers award winning solutions for compliant business processes focused on KOL Management, Medical Affairs Programs, Grant Funding & Study Management, and Speaker Programs. OpenQ’s solutions currently support compliance initiatives at 8 of the Top 10 Pharmaceutical and 3 of the Top 5 Medical Device Companies. For more information, visit www.openq.com.

# # #

Read the full story at http://www.prweb.com/releases/2010/06/prweb4153714.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. OpenQ Announces the Release of openIIS 2.5
2. Drug Information Association (DIA) Announces New Clinical Safety and Pharmacovigilance Certificate Program
3. Concord Medical Services Holdings Limited Announces Pricing of Initial Public Offering on the New York Stock Exchange
4. Pluromed Announces Completion of Enrollment in LeGoo™ Cardiac Bypass Clinical Trial
5. Nuvo Research announces early redemption of 5% convertible debentures
6. China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009
7. WebMD Health Corp. Announces Preliminary Results of Its Tender Offer
8. Good Vibrations Announces Enhanced Education Program
9. Young Innovations, Inc. Announces Record EPS for the Year
10. TeamHealth Holdings, Inc. Announces Fourth Quarter and Full Fiscal 2009 Earnings Release Date and Conference Call
11. Sunquest Announces Significant Speaker Schedule for HIMSS 2010
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
openQ Announces the Formation of a Compliance Advisory Board 
(Date:12/4/2016)... , ... December 03, 2016 , ... While James Earl ... serving as host for in a show called "Front Page". One of the forthcoming ... years, breast cancer rates have plummeted in large part due to early detection. Like ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to ... advantage of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser ... of age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and ... will speak at the American Conference Institute’s 21st Drug & Medical Device Litigation ... Lead Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device ...
(Date:12/2/2016)... ... December 02, 2016 , ... More than 100 business, civic, ... to attend the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. 9, 2016. This inaugural event, ... and operating support to UNCF-member institutions, including Miles College, Oakwood University, Tuskegee University, ...
(Date:12/2/2016)... ... , ... The annual time frame to change Medicare health and prescription drug ... 7th. Currently-enrolled Medicare beneficiaries who are looking to switch from their current plan to ... make changes during this period order for their new policy to go into effect ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... 2016  Results from the Phase II SUSTAIN study ... reduced the median annual rate of sickle cell-related pain ... 2.98, p=0.010) in patients with or without hydroxyurea therapy ... being featured in the official press briefing at the ... Meeting and presented during the Plenary Scientific Session tomorrow ...
(Date:12/2/2016)... December 2, 2016 - bioLytical lanza el INSTI HIV ... la OMS     Continue Reading ... ... , , bioLytical ... anunciado hoy que está expandiendo el lanzamiento de su INSTI HIV Self Test ...
(Date:12/2/2016)... December 2, 2016 According to the ... Market Study on Automated Endoscope Reprocessors: Single Basin Automated Endoscope ... 8.6% Between 2016 and 2024 " the global automated endoscope reprocessors market was ... to expand at a CAGR of 7.2% during an eight-year ... 1,367.6 Mn by 2024. ...
Breaking Medicine Technology: